LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Steroids in COVID-19: Tailor-made or "one size fits all"?

    Goel, Ayush / Ray, Animesh

    Advances in respiratory medicine

    2022  

    Abstract: Since the RECOVERY trial, steroids have endorsed by all guidelines for treating moderate-severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 days. However, in clinical practice, there are numerous occasions where the role ... ...

    Abstract Since the RECOVERY trial, steroids have endorsed by all guidelines for treating moderate-severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 days. However, in clinical practice, there are numerous occasions where the role of steroids cannot be extrapolated from current evidence: patients on immunosuppression, patients with persistent oxygen requirement after ten days of therapy, etc. We highlight the existing caveats and the need for further research and discussion.
    Language English
    Publishing date 2022-01-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2893877-X
    ISSN 2543-6031 ; 2451-4934
    ISSN (online) 2543-6031
    ISSN 2451-4934
    DOI 10.5603/ARM.a2022.0005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: An Empirical Review of Adversarial Defenses

    Goel, Ayush

    2020  

    Abstract: From face recognition systems installed in phones to self-driving cars, the field of AI is witnessing rapid transformations and is being integrated into our everyday lives at an incredible pace. Any major failure in these system's predictions could be ... ...

    Abstract From face recognition systems installed in phones to self-driving cars, the field of AI is witnessing rapid transformations and is being integrated into our everyday lives at an incredible pace. Any major failure in these system's predictions could be devastating, leaking sensitive information or even costing lives (as in the case of self-driving cars). However, deep neural networks, which form the basis of such systems, are highly susceptible to a specific type of attack, called adversarial attacks. A hacker can, even with bare minimum computation, generate adversarial examples (images or data points that belong to another class, but consistently fool the model to get misclassified as genuine) and crumble the basis of such algorithms. In this paper, we compile and test numerous approaches to defend against such adversarial attacks. Out of the ones explored, we found two effective techniques, namely Dropout and Denoising Autoencoders, and show their success in preventing such attacks from fooling the model. We demonstrate that these techniques are also resistant to both higher noise levels as well as different kinds of adversarial attacks (although not tested against all). We also develop a framework for deciding the suitable defense technique to use against attacks, based on the nature of the application and resource constraints of the Deep Neural Network.

    Comment: 19 pages, 8 Figures, Report Reviewed by Vivek Menon
    Keywords Computer Science - Cryptography and Security ; Computer Science - Artificial Intelligence
    Subject code 006
    Publishing date 2020-12-10
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Outcome of Patients on Prolonged V-V ECMO at a Tertiary Care Center in India.

    Goel, Kishen / Chakraborty, Arpan / Goel, Ayush

    Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

    2023  Volume 27, Issue 11, Page(s) 790–794

    Abstract: Introduction: Extracorporeal membrane oxygenation (ECMO) is a life-support system that provides cardiopulmonary support. With recent advances, the duration of ECMO has increased but data on the outcomes of prolonged V-V ECMO are limited and inconsistent. ...

    Abstract Introduction: Extracorporeal membrane oxygenation (ECMO) is a life-support system that provides cardiopulmonary support. With recent advances, the duration of ECMO has increased but data on the outcomes of prolonged V-V ECMO are limited and inconsistent.
    Materials and methods: It is a retrospective observational study done at a tertiary care center in Kolkata to study the outcome of patients receiving prolonged V-V ECMO defined as >14 days.
    Observation: A total of 22 patients received prolonged ECMO support. Fifteen patients (68.2%) had severe coronavirus disease-2019 (COVID-19). The mean duration of invasive mechanical ventilation (IMV) before ECMO was 5 days. Baseline PaO
    Conclusion: Duration of ECMO support alone should not represent a basis for decision making to decide futility or continuation of ECMO support. Prolonged ECMO in acute respiratory distress syndrome (ARDS) has minor complications and can lead to recovery in almost one-third of the patients.
    How to cite this article: Goel K, Chakraborty A, Goel A. Outcome of Patients on Prolonged V-V ECMO at a Tertiary Care Center in India. Indian J Crit Care Med 2023;27(11):790-794.
    Language English
    Publishing date 2023-10-23
    Publishing country India
    Document type Journal Article
    ZDB-ID 2121263-6
    ISSN 1998-359X ; 0972-5229
    ISSN (online) 1998-359X
    ISSN 0972-5229
    DOI 10.5005/jp-journals-10071-24554
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review.

    Bhardwaj, Ankit / Mishra, Hara Prasad / Goel, Ayush / Gupta, Ashi

    Therapeutic advances in ophthalmology

    2023  Volume 15, Page(s) 25158414231199541

    Abstract: SARS-CoV-2 affects the nervous system directly by neurotoxic action, by binding to angiotensin-converting enzyme-2 (ACE2) receptors or indirectly by inducing cytokine storm leading to disruption of the blood-brain barrier, immunological mediation, ... ...

    Abstract SARS-CoV-2 affects the nervous system directly by neurotoxic action, by binding to angiotensin-converting enzyme-2 (ACE2) receptors or indirectly by inducing cytokine storm leading to disruption of the blood-brain barrier, immunological mediation, increasing blood coagulation and as a trigger for autoimmune-mediated demyelinating injuries in the central nervous system. In COVID-19 neuro-ophthalmological manifestations are not so common. Optic neuritis is the result of optic nerve inflammation and has varied causes. In many patients, signs of inflammation are not visible on the fundus, and it usually manifests as papillitis-anterior neuritis, retrobulbar neuritis or visible optic nerve oedema. We are reporting a case of a middle-aged adult diagnosed with myelin oligodendrocyte glycoprotein (MOG) antibody-positive optic neuritis of the right eye post-COVID-19 disease. Routine biochemical and haematological investigations, including electrolytes and hepatic and renal functions, were normal. In cerebrospinal fluid (CSF) - glucose 63.8 mg/dL, protein 39.1 mg/dL and ADA - 1 µ/L. No oligoclonal bands of immunoglobulin G (IgG) were seen on high-resolution electrophoresis. Serum Anti-MOG-antibodies were positive. A gadolinium-contrast magnetic resonance imaging (MRI) of the brain and orbits shows post-contrast enhancement in the superior aspect of the right intraconal soft tissue. The right optic nerve appears bulky and heterogeneous with peripheral post-contrast enhancement along its entire length suggestive of neuritis. A diagnosis of MOG antibody-positive optic neuritis was made, and the patient was treated with an injection of Methylprednisolone with intravenous immunoglobulin. Each day, the evaluation of the right eye showed remarkable improvement from finger counting to 6/6 vision. The patient was discharged on the 9th day of admission. We can conclude that early diagnosis was essential for improving the long-term outcome of the patient.
    Language English
    Publishing date 2023-10-06
    Publishing country United States
    Document type Case Reports
    ISSN 2515-8414
    ISSN (online) 2515-8414
    DOI 10.1177/25158414231199541
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Neuroleptic malignant syndrome in a case of extra-pontine myelinolysis: On the horns of dilemma.

    Arora, Umang / Goel, Ayush / Ray, Animesh / Vikram, Naval K

    Drug discoveries & therapeutics

    2022  Volume 16, Issue 3, Page(s) 145–147

    Abstract: Osmotic demyelination syndrome (ODS) and neuroleptic malignant syndrome (NMS) lead to severe neurological sequalae. Though currently thought to be different syndromes, literature suggests a relation between the two. We present the case of a 45-year-old ... ...

    Abstract Osmotic demyelination syndrome (ODS) and neuroleptic malignant syndrome (NMS) lead to severe neurological sequalae. Though currently thought to be different syndromes, literature suggests a relation between the two. We present the case of a 45-year-old male who was found to have chronic severe hyponatremia and underwent rapid correction of sodium and developed parkinsonism features. Magnetic resonance imaging (MRI) confirmed extrapontine myelinolysis (a type of ODS). The patient received haloperidol for agitated behavior and developed new features of rigidity, fever, tachycardia and elevated creatine phosphokinase (CPK) levels and thus neuroleptic malignant syndrome was suspected to overlap with ODS. We report this case highlighting the difficulty in differentiating the between ODS and NMS and their relationship.
    MeSH term(s) Humans ; Hyponatremia/chemically induced ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Myelinolysis, Central Pontine/chemically induced ; Myelinolysis, Central Pontine/diagnostic imaging ; Neuroleptic Malignant Syndrome/diagnosis ; Neuroleptic Malignant Syndrome/etiology ; Sodium
    Chemical Substances Sodium (9NEZ333N27)
    Language English
    Publishing date 2022-06-25
    Publishing country Japan
    Document type Case Reports ; Journal Article
    ZDB-ID 2568828-5
    ISSN 1881-784X ; 1881-784X
    ISSN (online) 1881-784X
    ISSN 1881-784X
    DOI 10.5582/ddt.2021.01012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer.

    Manzar, Nishat / Khan, Umar Khalid / Goel, Ayush / Carskadon, Shannon / Gupta, Nilesh / Palanisamy, Nallasivam / Ateeq, Bushra

    iScience

    2024  Volume 27, Issue 3, Page(s) 108794

    Abstract: Elevated serine peptidase inhibitor, Kazal type 1 (SPINK1) levels in ∼10%-25% of prostate cancer (PCa) patients associate with aggressive phenotype, for which there are limited treatment choices and dismal clinical outcomes. Using an integrative ... ...

    Abstract Elevated serine peptidase inhibitor, Kazal type 1 (SPINK1) levels in ∼10%-25% of prostate cancer (PCa) patients associate with aggressive phenotype, for which there are limited treatment choices and dismal clinical outcomes. Using an integrative proteomics approach involving label-free phosphoproteome and proteome profiling, we delineated the downstream signaling pathways involved in SPINK1-mediated tumorigenesis and identified tyrosine kinase KIT as highly enriched. Furthermore, high to moderate levels of KIT expression were detected in ∼85% of SPINK1-positive PCa specimens. We show KIT signaling orchestrates SPINK1-mediated oncogenesis, and treatment with KIT inhibitor reduces tumor growth and metastases in preclinical mice models. Mechanistically, KIT signaling modulates WNT/β-catenin pathway and confers stemness-related features in PCa. Notably, inhibiting KIT signaling led to restoration of AR/REST levels, forming a feedback loop enabling SPINK1 repression. Overall, we uncover the role of KIT signaling downstream of SPINK1 in maintaining lineage plasticity and provide distinct treatment modalities for advanced-stage SPINK1-positive patients.
    Language English
    Publishing date 2024-01-04
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2024.108794
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Is Cytology of Purulent Aspirates Imperative?: An Instance of a Periappendicular Abscess.

    Rai Santosh, P V / Sreeram, Saraswathy / Goel, Ayush M / Bhat, Akshatha

    Journal of cytology

    2020  Volume 37, Issue 2, Page(s) 112–113

    Language English
    Publishing date 2020-04-02
    Publishing country India
    Document type Journal Article
    ZDB-ID 645018-0
    ISSN 0970-9371
    ISSN 0970-9371
    DOI 10.4103/JOC.JOC_89_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A study on the morbid histopathological changes in COVID-19 patients with or without comorbidities using minimally invasive tissue sampling.

    Goel, Ayush / Ray, Animesh / Chavan, Amitkumar / Sahni, Shubham / Gupta, Baidhnath K / Raut, Shrawan K / Agarwal, Shubham / Nehra, Jagbir / Somu, Bharadhan / Raja, Ragu / Aakansha / Nagpal, Chitrakshi / Rajanna, Chaithra / Shahi, Anand / Rajendran, Anand / Varadrajan, Ashwin / Hasan, Inamul / Choppala, Pratheek / Priyadarshi, Megha /
    Jain, Deepali / Subramanian, Arulselvi / Arava, Sudheer / Singh, Geetika / Das, Prasenjit / Sarkar, Chitra / Nischal, Neeraj / Soneja, Manish / Jorwal, Pankaj / Trikha, Anjan / Wig, Naveet

    Journal of medical virology

    2022  Volume 95, Issue 1, Page(s) e28384

    Abstract: COVID-19 causes morbid pathological changes in different organs including lungs, kidneys, liver, and so on, especially in those who succumb. Though clinical outcomes in those with comorbidities are known to be different from those without-not much is ... ...

    Abstract COVID-19 causes morbid pathological changes in different organs including lungs, kidneys, liver, and so on, especially in those who succumb. Though clinical outcomes in those with comorbidities are known to be different from those without-not much is known about the differences at the histopathological level. To compare the morbid histopathological changes in COVID-19 patients between those who were immunocompromised (Gr 1), had a malignancy (Gr 2), or had cardiometabolic conditions (hypertension, diabetes, or coronary artery disease) (Gr 3), postmortem tissue sampling (minimally invasive tissue sampling [MITS]) was done from the lungs, kidney, heart, and liver using a biopsy gun within 2 hours of death. Routine (hematoxylin and eosin) and special staining (acid fast bacilli, silver methanamine, periodic acid schiff) was done besides immunohistochemistry. A total of 100 patients underwent MITS and data of 92 patients were included (immunocompromised: 27, malignancy: 18, cardiometabolic conditions: 71). In lung histopathology, capillary congestion was more in those with malignancy, while others like diffuse alveolar damage, microthrombi, pneumocyte hyperplasia, and so on, were equally distributed. In liver histopathology, architectural distortion was significantly different in immunocompromised; while steatosis, portal inflammation, Kupffer cell hypertrophy, and confluent necrosis were equally distributed. There was a trend towards higher acute tubular injury in those with cardiometabolic conditions as compared to the other groups. No significant histopathological difference in the heart was discerned. Certain histopathological features were markedly different in different groups (Gr 1, 2, and 3) of COVID-19 patients with fatal outcomes.
    MeSH term(s) Humans ; COVID-19/pathology ; SARS-CoV-2 ; Lung/pathology ; Thrombosis ; Heart
    Language English
    Publishing date 2022-12-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.28384
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Guidelines for endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA): Joint Indian Chest Society (ICS)/Indian Association for Bronchology (IAB) recommendations.

    Mohan, Anant / Madan, Karan / Hadda, Vijay / Mittal, Saurabh / Suri, Tejas / Shekh, Irfan / Guleria, Randeep / Khader, Abdul / Chhajed, Prashant / Christopher, Devasahayam J / Swarnakar, Rajesh / Agarwal, Ritesh / Aggarwal, Ashutosh Nath / Aggarwal, Shubham / Agrawal, Gyanendra / Ayub, Irfan Ismail / Bai, Muniza / Baldwa, Bhvya / Chauhan, Abhishek /
    Chawla, Rakesh / Chopra, Manu / Choudhry, Dhruva / Dhar, Raja / Dhooria, Sahajal / Garg, Rakesh / Goel, Ayush / Goel, Manoj / Goyal, Rajiv / Gupta, Nishkarsh / Manjunath, B G / Iyer, Hariharan / Jain, Deepali / Khan, Ajmal / Kumar, Raj / Koul, Parvaiz A / Lall, Ajay / Arunachalam, M / Madan, Neha K / Mehta, Ravindra / Loganathan, N / Nath, Alok / Nangia, Vivek / Nene, Amita / Patel, Dharmesh / Pattabhiraman, V R / Raja, Arun / Rajesh, Benin / Rangarajan, Amith / Rathi, Vidushi / Sehgal, Inderpaul Singh / Shankar, Sujay H / Sindhwani, Girish / Singh, Pawan K / Srinivasan, Arjun / Talwar, Deepak / Thangakunam, Balamugesh / Tiwari, Pawan / Tyagi, Rahul / Chandra, V Naren / Sharada, V / Vadala, Rohit / Venkatnarayan, Kavitha

    Lung India : official organ of Indian Chest Society

    2023  Volume 40, Issue 4, Page(s) 368–400

    Abstract: Over the past decade, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become an indispensable tool in the diagnostic armamentarium of the pulmonologist. As the expertise with EBUS-TBNA has evolved and several innovations ... ...

    Abstract Over the past decade, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become an indispensable tool in the diagnostic armamentarium of the pulmonologist. As the expertise with EBUS-TBNA has evolved and several innovations have occurred, the indications for its use have expanded. However, several aspects of EBUS-TBNA are still not standardized. Hence, evidence-based guidelines are needed to optimize the diagnostic yield and safety of EBUS-TBNA. For this purpose, a working group of experts from India was constituted. A detailed and systematic search was performed to extract relevant literature pertaining to various aspects of EBUS-TBNA. The modified GRADE system was used for evaluating the level of evidence and assigning the strength of recommendations. The final recommendations were framed with the consensus of the working group after several rounds of online discussions and a two-day in-person meeting. These guidelines provide evidence-based recommendations encompassing indications of EBUS-TBNA, pre-procedure evaluation, sedation and anesthesia, technical and procedural aspects, sample processing, EBUS-TBNA in special situations, and training for EBUS-TBNA.
    Language English
    Publishing date 2023-07-07
    Publishing country India
    Document type Journal Article
    ZDB-ID 2410801-7
    ISSN 0974-598X ; 0970-2113
    ISSN (online) 0974-598X
    ISSN 0970-2113
    DOI 10.4103/lungindia.lungindia_510_22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling.

    Ray, Animesh / Jain, Deepali / Goel, Ayush / Agarwal, Shubham / Swaroop, Shekhar / Das, Prasenjit / Arava, Sudheer Kumar / Mridha, Asit Ranjan / Nambirajan, Aruna / Singh, Geetika / Arulselvi, S / Mathur, Purva / Kumar, Sanchit / Sahni, Shubham / Nehra, Jagbir / Nazneen / Bm, Mouna / Rastogi, Neha / Mahato, Sandeep /
    Gupta, Chaavi / Bharadhan, S / Dhital, Gaurav / Goel, Pawan / Pandey, Praful / Kn, Santosh / Chaudhary, Shitij / Keri, Vishakh C / Chauhan, Vishal Singh / Mahishi, Niranjan / Shahi, Anand / R, Ragu / Gupta, Baidnath K / Aggarwal, Richa / Soni, Kapil Dev / Nischal, Neeraj / Soneja, Manish / Lalwani, Sanjeev / Sarkar, Chitra / Guleria, Randeep / Wig, Naveet / Trikha, Anjan

    Expert review of respiratory medicine

    2021  Volume 15, Issue 10, Page(s) 1367–1375

    Abstract: Objectives: To study the histopathology of patients dying of COVID-19 using post-mortem minimally invasive sampling techniques.: Methods: This was a single-center observational study conducted at JPNATC, AIIMS. Thirty-seven patients who died of COVID- ...

    Abstract Objectives: To study the histopathology of patients dying of COVID-19 using post-mortem minimally invasive sampling techniques.
    Methods: This was a single-center observational study conducted at JPNATC, AIIMS. Thirty-seven patients who died of COVID-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with hematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was detected using IHC with primary antibodies.
    Results: The mean age was 48.7 years and 59.5% were males. Lung histopathology showed diffuse alveolar damage in 78% patients. Associated bronchopneumonia was seen in 37.5% and scattered microthrombi in 21% patients. Immunopositivity for SARS-CoV-2 was observed in Type II pneumocytes. Acute tubular injury with epithelial vacuolization was seen in 46% of renal biopsies. Seventy-one percent of liver biopsies showed Kupffer cell hyperplasia and 27.5% showed submassive hepatic necrosis.
    Conclusions: Predominant finding was diffuse alveolar damage with demonstration of SARS-CoV-2 protein in the acute phase. Microvascular thrombi were rarely identified in any organ. Substantial hepatocyte necrosis, Kupffer cell hypertrophy, microvesicular, and macrovesicular steatosis unrelated to microvascular thrombi suggested that liver might be a primary target of COVID-19.
    MeSH term(s) Autopsy ; COVID-19 ; Humans ; Lung ; Male ; Middle Aged ; SARS-CoV-2 ; Tertiary Care Centers
    Language English
    Publishing date 2021-07-24
    Publishing country England
    Document type Journal Article ; Observational Study
    ZDB-ID 2479146-5
    ISSN 1747-6356 ; 1747-6348
    ISSN (online) 1747-6356
    ISSN 1747-6348
    DOI 10.1080/17476348.2021.1951708
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top